Organon and Samsung Bioepis add ustekinumab biosimilar to Canada deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. DCOY
5. SPY
6. MSFT
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to Organon and Samsung Bioepis add ustekinumab biosimilar to Canada deal
(NYSE: OGN) Delayed: 13.70 +0.02 (0.15%)
Previous Close $13.68    52 Week High $8.00 
Open $13.70    52 Week Low $8.00 
Day High $13.72    P/E N/A 
Day Low $13.68    EPS $0.00 
Volume 1,365,159